CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state-of-the art production facilities.

Press Releases

CV Sciences, Inc. to Present at the 10th Annual LD Micro Main Event

LOS ANGELES, CA / ACCESSWIRE / November 28, 2017 / CV Sciences, Inc., (OTCQB: CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil and developer of specialty pharmaceutical therapeutics, announced today that it will be presenting at the 10th annual LD Micro Main Event on Wednesday, December 6th at 10:30 AM PST / 1:30 PM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Mr. Joseph Dowling, Chief Financial Officer of CV Sciences, Inc. will be presenting and meeting with investors.

The presentation will highlight CV Sciences’ line of CBD consumer products and provide details about its lead drug candidate, CVSI-007, which utilizes synthetically-formulated CBD for use in the treatment of smokeless tobacco addiction.

The LD Micro Main Event is the largest independent conference for small/micro cap companies and will feature 250 names presenting to an audience of over 1,000 attendees. In addition, there will be a variety of speakers/panelists discussing topics of interest to investors and issuers, along with coordinate evening events.

View CV Sciences’ profile here:

News Compliments of Accesswire

About CV Sciences, Inc.
CV Sciences, Inc. (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. CV Sciences, Inc. has primary offices and facilities in Las Vegas, Nevada and San Diego, California.  Additional information is available from or by visiting

About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into several influential conferences annually. In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. For those interested in attending, please contact David Scher at or visit for more information.

Robert Haag
Managing Director
IRTH Communications
866-976- 4784

Source: CV Sciences, Inc. via LD Micro

Leave a Reply

Your email address will not be published. Required fields are marked *

CV Sciences does not recruit through Facebook or any other social media sites. When applying for a job, please ensure you communicate with our HR Department: